InvestorsHub Logo
Followers 42
Posts 4131
Boards Moderated 0
Alias Born 01/04/2017

Re: None

Thursday, 05/26/2022 11:47:02 AM

Thursday, May 26, 2022 11:47:02 AM

Post# of 700215
You know... us stockholders are unhappy about current share price, but after looking at what is going on, it seems nwbo management is going by the correct route, informing and presenting data to scientists, brain surgeons, oncologists, and clinicians FIRST to get them on board with this immunotherapy because THEY will be the ones recommending this treatment for their patients. Share price will come...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News